Table IV. Type of Rash and Associated Diseases Caused by Infectious Agents Clinical Disease Description Syndrome

Total Page:16

File Type:pdf, Size:1020Kb

Table IV. Type of Rash and Associated Diseases Caused by Infectious Agents Clinical Disease Description Syndrome Table IV. Type of Rash and Associated Diseases Caused by Infectious Agents Clinical Disease Description Syndrome CENTRAL DISTRIBUTED MACULOPAPULAR ERUPTIONS Discrete blanching erythematous “brick-red” lesions, confluent rash Cough, coryza, postration, Measles spreads from hair downward, conjunctivitis sparing palms and soles; lasts >3 d; Koplik´s spots. Prominent posterior cervical Rubella triangle and/or suboccipital Usually no serious systemic adenopathy. Punctate soft palate symptoms macules, Forchheimer spots. Common in children 3-12 years, Diffuse eruption (sparing face). mild fever. In adults, arthralgias Exanthema subitum (roseola) Resolves within 2 days. are common, history of exposure to an infected child “Slapped cheek” appearance and Common in children 3-12 years, net-like rash. Bright-red mild fever. In adults arthalgias Erythema infectiosum appearance, followed by diffuse and history of exposure to an lacy reticular rash that waxes and affected child wanes over 3 wks. Pharyngitis, lymphadenopathy, Nonspecific diffuse macules and arthralgias, myalgias, fatigue, Primary HIV infection papules, urticarial. headache and gastrointestinal symptoms Infectious mononucleosis Adolescents and young adults, fever, malaise, sweats, anorexia Diffuse maculopapular eruption, nausea, chills, sore throat, urticaria in some cases, periorbital hepatosplenomegaly, cervical edemal, palatal petechiae. lymphadenopathy, atypical lymphocytosis, heterophile antibodies Maculopapular eruption, sparing Exposure to body lice; or rat or Typhus face, palms, soles. cat fleas. Headache, myalgias David L Wyles ! 7/8/16 16:51 Headache, myalgias, regional Eschar at site of bite: Deleted: h lymphadenopathy. Exposure to maculopapular eruption on Rickettsial spotted fever ticks (Mediterranean region, proximal extremities, spreading to India, Africa, Australia, Siberia, trunk and face. Mongolia) Tick born. In United States Southeast and southern Central maculopapular eruption Ehrlichiosis Midwest. Headache, myalgias, sparing extremities, palms, soles. nausea, emesis, diarrhea, malaise, altered mental status, elevated transaminase levels, leukopenia and hyponatremia. Contaminated food or water. Blanchable erythematous Abdominal pain and diarrhea, Typhoid fever macules and papules 2-4 mm, headache, myalgias, usually on trunk. hepatosplenomegaly Erythematous annular papules Patients with rheumatic fever. and plaques occurring in waves Pharyngitis before polyarthritis, Erythema marginatum over trunk and proximal carditis, chorea and extremities, resolving in hour. subcutaneous nodules Exposure to water contaminated Maculopapular eruption; with animal urine. Myalgias, Leptospirosis conjunctivitis, sclera hemorrhage aseptic meningitis. Weil´s in some cases. disease (fulminant form): icterohemorrhagic Papule expanding to Bite or tick vector. Headache, erythematous annular lesion with myalgias, chills, photophobia central clearing. Sometimes Lyme disease (acute). CNS disease, concentric rings, or indurated, or myocardial disease, arthritis vesicular center, or multiple weeks to months later secondary lesions are observed. Exposure to ticks or body lice. Central rash at end of febrile Relapsing fever Recurrent fever, headache, episode; sometimes petechiae. myalgias, hepatosplenomegaly Rat bite (primarily found in Asia). Eschar at site of bite. Red-brown Rat bite Regional lymphadenopathy, central rash or blotchy violaceous. recurrent fevers if untreated Dengue is characterized by retro- orbital pain, muscle and joint pain. Chikungunya by long-standing arthralgias. Morbiliform rash, fever, headache, Dengue, Chikungunya, Zika muscle and joint pain. Zika virus is mild and self-limited, David L Wyles ! 7/8/16 16:52 but there is an association Deleted: c between maternal infection and adverse fetal outcome, such as congenital microcephaly. History of travel to endemic areas. Abrupt onset of symptoms: Headache, chills, high fever, malaise, weakness. Progression Diffuse erythematous rash, which after about 5 days: abdominal spreads from hair, buttocks, arms pain, nausea, aqueous diarrhea, Ebola and legs, and then extended to haemorrhagic symptoms, altered trunk. Desquamation in palms, mental status. Travel history soles and limbs. to/from West Africa. Health-care workers in contact with Ebola patients. PERIPHERAL ERUPTIONS Subacute course: Osler´s nodes Abnormal heart valve. Bacterial endocarditis (tender pink nodules on finger or Intravenous drug users. New toe pads), petechiae on skin and heart murmur. mucosa, splinter hemorrhages; Acute course: Janeway lesions (painless erythematous or hemorrhagic macules on palms and soles). Central erythema surrounded by area of clearing and another rim of erythema) up to 2 cm. Starts on Drug intake. Herpes simplex, backs of hands and feet and on Erythema multiforme Mycoplasma pneumonia extensor surfaces of arms and infection. legs, symmetric, may involve palms, soles, oral mucous membranes of lips. Tender vesicles, erosions in Primarily children younger than mouth. 0.25 cm papules on hands Hand-foot and mouth disease 10 yr. Multiple family members. and feet with rim of erythema Transient fever. evolving into tender vesicles. Tick vector. In United States, more common in southeastern Rash beginning on wrists and and southwest-central. Seasonal ankles and spreading outbreaks. Short incubation centripetally; appears on palms Rocky Mountain Spotted fever period: Headache, fever, and soles late in disease. Lesions malaise, conjunctival suffusion evolution from blanchable and myalgias (adults). Abdominal macules to petechiae. pain (children). Mortality up to 40% if untreated. Coincident primary chancre in 10% of cases; cooper-colored, scaly popular eruption, diffuse but Sexually transmitted. Fever, Secondary syphilis prominent on palms and soles; constitutional symptoms. condyloma latum, mucous patches and alopecia in some cases. CONFLUENT DESQUAMATIVE ERYTHEMAS Diffuse blanchable erythema beginning on face and spreading Most common in children 2-10 yr. to trunk and extremities; Usually follows group A circumoral pallor, sandpaper Scarlet fever Streptcoccal pharyngitis. Fever, texture to skin, accentuation of pharyngitis, headache, vomiting linear erythema in skin folds and abdominal pain. (Pastia lines); enanthem of white evolving into red. Occurs in setting of severe group A Streptococcal infections. Streptococcal toxic shock syndrome Rash often scarlatiform. Multiorgan failure, hypotension, 30% mortality rate. Painful, diffuse erythema involving Colonization with toxin- palms and flexure areas, profuse Staphylococcal toxic shock producing S.aureus. Fever erythema of mucosal surfaces. syndrome >39°C, hypotension, multiorgan Progress to large, flaccid bullae. dysfunction. Desquamation 7-10 days of illness. Diffuse tender erythema, often Colonization with toxin- Staphylococcal scalded-skin with bullae and desquamation: producing S.aureus. Irritability, syndrome Nikolsky´s sign. nasal or conjunctival secretions. Rash on hands and feet starting 3-5 days after onset of fever in Bilateral conjuntival injection, children younger than 8 yrs hyperemic oral mucosa and red, Kawasaki disease (usually younger than 4 yrs) dry, cracked, bleeding lip injected blanching macular exanthema on pharynx, cervical adenopathy, trunk, especially groin and diaper coronary artery vasculitis. area,. Life-threating condition, rapidly spreading infection that involves subcutaneous tissue and superficial fascia and typically Black eschar that sloughs off, spares muscle tissue. Type I Necrotizing fasciitis crepitus, dusky blue discoloration, usually polymicrobial and type II erythema. usually monomicrobial. Fever, warmth, swelling, edema, pain out of proportion, systemic toxicity. VESICULOBULLOUS ERUPTIONS Usually affects children. More Macules, papules (sometimes common in winter and spring. Varicella (chicken- pox) umbilicated), pustules then Malaise, mild disease in children, forming crusting. more severe disease in adults and in immunocompromised. Zoster cutaneous dissemination: Immunosupressed individuals. Dissemination herpes-virus >25 lesions extending outside Visceral organ involvement infection involved dermatome; HSV: (especially of liver) may occur. mucocutaneous involvement. Patients with diabetes, renal Erythematous lesions evolving failure, cirrhosis; ingestion of Vibrio vulnificus infection into hemorrhagic bullae and then contaminated saltwater seafood. into necrotic lesions. Hypotension; 50% mortality. Indurated plaque evolving into hemorrhagic bulla or pustule that Usually affects neutropenic sloughs, resulting in eschar patients; occurs in up to 28% of Ecthyma gangrenosum formation; erythematous halo; individual with Pseudomonas most common in axillary, groin, bacteremia. Sepsis. perianal regions. Eschar found at site of mite bite; generalized rash involving face, Urban settings, transmitted by trunk, extremities; may involve mouse mites. Headache, Rickettsial pox palms and soles; <100 papules myalgias, regional and plaques (2-10 mm), top of lymphadenopathy, mild disease. lesions develop vesicles that may evolve into pustules. NODULAR ERUPTIONS Subcutaneous nodules, Immunocompromised hosts. Disseminated infection fluctuance, draining common with Features vary with the organism. mycobacteria; necrotic nodules common with Aspergillus, Mucor. More common in females 15-30 Large violaceous, nonulcerative, years of age. Arthralgias (50%): Erythema nodosum subcutaneous nodules; exquisitely features vary with associated tender; usually on extremities.
Recommended publications
  • Reporting of Diseases and Conditions Regulation, Amendment, M.R. 289/2014
    THE PUBLIC HEALTH ACT LOI SUR LA SANTÉ PUBLIQUE (C.C.S.M. c. P210) (c. P210 de la C.P.L.M.) Reporting of Diseases and Conditions Règlement modifiant le Règlement sur la Regulation, amendment déclaration de maladies et d'affections Regulation 289/2014 Règlement 289/2014 Registered December 23, 2014 Date d'enregistrement : le 23 décembre 2014 Manitoba Regulation 37/2009 amended Modification du R.M. 37/2009 1 The Reporting of Diseases and 1 Le présent règlement modifie le Conditions Regulation , Manitoba Règlement sur la déclaration de maladies et Regulation 37/2009, is amended by this d'affections , R.M. 37/2009. regulation. 2 Schedules A and B are replaced with 2 Les annexes A et B sont remplacées Schedules A and B to this regulation. par les annexes A et B du présent règlement. Coming into force Entrée en vigueur 3 This regulation comes into force on 3 Le présent règlement entre en vigueur January 1, 2015, or on the day it is registered le 1 er janvier 2015 ou à la date de son under The Statutes and Regulations Act , enregistrement en vertu de Loi sur les textes whichever is later. législatifs et réglementaires , si cette date est postérieure. December 19, 2014 Minister of Health/La ministre de la Santé, 19 décembre 2014 Sharon Blady 1 SCHEDULE A (Section 1) 1 The following diseases are diseases requiring contact notification in accordance with the disease-specific protocol. Common name Scientific or technical name of disease or its infectious agent Chancroid Haemophilus ducreyi Chlamydia Chlamydia trachomatis (including Lymphogranuloma venereum (LGV) serovars) Gonorrhea Neisseria gonorrhoeae HIV Human immunodeficiency virus Syphilis Treponema pallidum subspecies pallidum Tuberculosis Mycobacterium tuberculosis Mycobacterium africanum Mycobacterium canetti Mycobacterium caprae Mycobacterium microti Mycobacterium pinnipedii Mycobacterium bovis (excluding M.
    [Show full text]
  • If Needed You Can Use Two Lines
    “IS AN OLD FOE MAKING A COMEBACK?” •Eyob Tadesse MD1; Samie Meskele MD1; Ankoor Biswas MD1 •Aurora Health Care, Milwaukee WI. NTRODUCTION abdomen gradually spread to her extremities, DISCUSSION I scalp, palms and soles. In association she had After being on the verge of elimination in shortness of breath, vague abdominal pain Generally, syphilis presents in HIV infected 2000 in the United States, syphilis cases have and loss of appetite, history of multiple sexual patients similar to general population yet with rebounded. Rates of primary and secondary partner, unprotected sex and prostitution. She some differences. Diagnosis is based on syphilis continued to increase overall during was recently diagnosed with HIV but not serologic test and microbiology. For serology, 2005–2013. Increases have occurred primarily started on treatment. both non treponemal antibody test, and among men, and particularly among men has specific treponemal antibody test should be used. Secondary syphilis in patients with HIV sex with men (MSM)(1). According to CDC During her admission her vital signs were has varied skin presentation, which can mimic report the incidence of primary and stable, she had pale conjunctivae, skin cutaneous lymphoma, mycobacterial secondary syphilis during 2015–2016, examination had demonstrated widespread macular and maculopapular skin lesions infection, bacillary angiomatosis, fungal increased 17.6% to 8.7 cases per 100,000 infections or Kaposi’s sarcoma. In our patient, population, the highest rate reported since involving the whole body including palms and soles. She also had thin, fragile scalp hair and she was having diffuse maculopapular rash, 1993(2). HIV and syphilis affect similar patient scalp hair loss without genital ulceration; involving palms and soles, significant hair loss, groups and co-infection is common(3).
    [Show full text]
  • Syphilis Staging and Treatment Syphilis Is a Sexually Transmitted Disease (STD) Caused by the Treponema Pallidum Bacterium
    Increasing Early Syphilis Cases in Illinois – Syphilis Staging and Treatment Syphilis is a sexually transmitted disease (STD) caused by the Treponema pallidum bacterium. Syphilis can be separated into four different stages: primary, secondary, early latent, and late latent. Ocular and neurologic involvement may occur during any stage of syphilis. During the incubation period (time from exposure to clinical onset) there are no signs or symptoms of syphilis, and the individual is not infectious. Incubation can last from 10 to 90 days with an average incubation period of 21 days. During this period, the serologic testing for syphilis will be non-reactive but known contacts to early syphilis (that have been exposed within the past 90 days) should be preventatively treated. Syphilis Stages Primary 710 (CDC DX Code) Patient is most infectious Chancre (sore) must be present. It is usually marked by the appearance of a single sore, but multiple sores are common. Chancre appears at the spot where syphilis entered the body and is usually firm, round, small, and painless. The chancre lasts three to six weeks and will heal without treatment. Without medical attention the infection progresses to the secondary stage. Secondary 720 Patient is infectious This stage typically begins with a skin rash and mucous membrane lesions. The rash may manifest as rough, red, or reddish brown spots on the palms of the hands, soles of the feet, and/or torso and extremities. The rash does usually does not cause itching. Rashes associated with secondary syphilis can appear as the chancre is healing or several weeks after the chancre has healed.
    [Show full text]
  • Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting As Cellulitis Kelly L
    Lehigh Valley Health Network LVHN Scholarly Works Department of Medicine Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed DO Lehigh Valley Health Network, [email protected] Nektarios I. Lountzis MD Lehigh Valley Health Network, [email protected] Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine Part of the Dermatology Commons, and the Medical Sciences Commons Published In/Presented At Reed, K., Lountzis, N. (2015, April 24). Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis. Poster presented at: Atlantic Dermatological Conference, Philadelphia, PA. This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an authorized administrator. For more information, please contact [email protected]. Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed, DO and Nektarios Lountzis, MD Lehigh Valley Health Network, Allentown, Pennsylvania Case Presentation: Discussion: Patient: 83 year-old Hispanic female Cutaneous tuberculosis (CTB) was first described in the literature in 1826 by Laennec and has since been History of Present Illness: The patient presented to the hospital for chest pain and shortness of breath and was treated for an NSTEMI. She was noted reported to manifest in a variety of clinical presentations. The most common cause is infection with the to have redness and swelling involving the right lower extremity she admitted to having for 5 months, which had not responded to multiple courses of antibiotics. She acid-fast bacillus Mycobacterium tuberculosis via either primary exogenous inoculation (direct implantation resided in Puerto Rico but recently moved to the area to be closer to her children.
    [Show full text]
  • In Diagnosis Must Be Based on Clinical Signs and Symptoms. in This Paper
    242 POST-GRADUATE MEDICAL JOURNAL August, 1938 Postgrad Med J: first published as 10.1136/pgmj.14.154.242 on 1 August 1938. Downloaded from SOME REMARKS ON DIFFERENTIAL DIAGNOSIS OF BLOOD DISEASES. By A. PINEY, M.D., M.R.C.P. (Assistant Physician, St. Mary's Hospital for Women and Children.) Differential diagnosis of blood diseases has been discussed time and again, but, as a rule, blood-pictures, rather than clinical features, have been taken into account, so that the impression has become widespread that the whole problem is one for the laboratory, rather than for the bed-side. It is obvious, however, that the first steps in diagnosis must be based on clinical signs and symptoms. In this paper, there- fore, certain outstanding clinical features of blood diseases, and various rather puzzling syndromes will be described. The outstanding external sign that leads the practitioner to consider the possi- bility of a blood disease is pallor, which is not quite so simple a state as is often supposed. It is, of course, well known that cutaneous pallor is not an infallible sign of anaemia, but it is often presumed that well-coloured mucous membranes are fairly good evidence that anaemia is not present. This is not necessarily true. The conjunctive may be bright pink in spite of anaemia, because mild inflammationProtected by copyright. may be present, masking the pallor. This is quite frequently due to irritation by eyelash dyes. Similarly, the finger-nails, which used to serve as a reliable index of pallor, are now found disguised with coloured varnish.
    [Show full text]
  • (ACIP) General Best Guidance for Immunization
    8. Altered Immunocompetence Updates This section incorporates general content from the Infectious Diseases Society of America policy statement, 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host (1), to which CDC provided input in November 2011. The evidence supporting this guidance is based on expert opinion and arrived at by consensus. General Principles Altered immunocompetence, a term often used synonymously with immunosuppression, immunodeficiency, and immunocompromise, can be classified as primary or secondary. Primary immunodeficiencies generally are inherited and include conditions defined by an inherent absence or quantitative deficiency of cellular, humoral, or both components that provide immunity. Examples include congenital immunodeficiency diseases such as X- linked agammaglobulinemia, SCID, and chronic granulomatous disease. Secondary immunodeficiency is acquired and is defined by loss or qualitative deficiency in cellular or humoral immune components that occurs as a result of a disease process or its therapy. Examples of secondary immunodeficiency include HIV infection, hematopoietic malignancies, treatment with radiation, and treatment with immunosuppressive drugs. The degree to which immunosuppressive drugs cause clinically significant immunodeficiency generally is dose related and varies by drug. Primary and secondary immunodeficiencies might include a combination of deficits in both cellular and humoral immunity. Certain conditions like asplenia and chronic renal disease also can cause altered immunocompetence. Determination of altered immunocompetence is important to the vaccine provider because incidence or severity of some vaccine-preventable diseases is higher in persons with altered immunocompetence; therefore, certain vaccines (e.g., inactivated influenza vaccine, pneumococcal vaccines) are recommended specifically for persons with these diseases (2,3). Administration of live vaccines might need to be deferred until immune function has improved.
    [Show full text]
  • HIV and the SKIN • Sudden Acute Exacerbations • Treatment Failure DR
    2018/08/13 KEY FEATURES • Atypical presentation of common disorders • Severe or exaggerated presentations HIV AND THE SKIN • Sudden acute exacerbations • Treatment failure DR. FREDAH MALEKA DERMATOLOGY UNIVERSITY OF PRETORIA:KALAFONG VIRAL INFECTIONS EXANTHEM OF PRIMARY HIV INFECTION • Exanthem of primary HIV infection • Acute retroviral syndrome • Herpes simplex virus (HSV) • Morbilliform rash (exanthem) : 2-4 weeks after HIV exposure • Varicella Zoster virus (VZV) • Typically generalised • Molluscum contagiosum (Poxvirus) • Pronounced on face and trunk, sparing distal extremities • Human papillomavirus (HPV) • Associated : fever, lymphadenopathy, pharyngitis • Epstein Barr virus (EBV) • DDX: drug reaction • Cytomegalovirus (CMV) • other viral infections – EBV, Enteroviruses, Hepatitis B virus 1 2018/08/13 HERPES SIMPLEX VIRUS(HSV) • Vesicular eruption due to HSV 1&2 • Primary lesion: painful, grouped vesicles on an erythematous base • HIV: attacks are more frequent and severe • : chronic, non-healing, deep ulcers, with scarring and tissue destruction • CLUE: severe pain and recurrences • DDX: syphilis, chancroid, lymphogranuloma venereum • Tzanck smear, Histology, Viral culture HSV • Treatment: Acyclovir 400mg tds 7-10 days • Alternatives: Valacyclovir and Famciclovir • In setting of treatment failure, viral isolates tested for resistance against acyclovir • Alternative drugs: Foscarnet, Cidofovir • Chronic suppressive therapy ( >8 attacks per year) 2 2018/08/13 VARICELLA • Chickenpox • Presents with erythematous papules and umbilicated
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Bacterial Infections Diseases Picture Cause Basic Lesion
    page: 117 Chapter 6: alphabetical Bacterial infections diseases picture cause basic lesion search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 118 6.1 Impetigo alphabetical Bullous impetigo Bullae with cloudy contents, often surrounded by an erythematous halo. These bullae rupture easily picture and are rapidly replaced by extensive crusty patches. Bullous impetigo is classically caused by Staphylococcus aureus. cause basic lesion Basic Lesions: Bullae; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 119 alphabetical Non-bullous impetigo Erythematous patches covered by a yellowish crust. Lesions are most frequently around the mouth. picture Lesions around the nose are very characteristic and require prolonged treatment. ß-Haemolytic streptococcus is cause most frequently found in this type of impetigo. basic lesion Basic Lesions: Erythematous Macule; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Ecthyma page: 120 6.2 Ecthyma alphabetical Slow and gradually deepening ulceration surmounted by a thick crust. The usual site of ecthyma are the legs. After healing there is a permanent scar. The pathogen is picture often a streptococcus. Ecthyma is very common in tropical countries. cause basic lesion Basic Lesions: Crusts; Ulcers Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Folliculitis page: 121 6.3 Folliculitis
    [Show full text]
  • Urticaria and Prodromal Symptoms Including Erythema Marginatum in Danish Patients with Hereditary Angioedema
    University of Southern Denmark Urticaria and Prodromal Symptoms Including Erythema Marginatum in Danish Patients with Hereditary Angioedema Rasmussen, Eva R; Valente de Freitas, Priscila; Bygum, Anette Published in: Acta Dermatovenereologica DOI: 10.2340/00015555-2233 Publication date: 2016 Document version: Final published version Document license: CC BY Citation for pulished version (APA): Rasmussen, E. R., Valente de Freitas, P., & Bygum, A. (2016). Urticaria and Prodromal Symptoms Including Erythema Marginatum in Danish Patients with Hereditary Angioedema. Acta Dermatovenereologica, 96(3), 373- 376. https://doi.org/10.2340/00015555-2233 Go to publication entry in University of Southern Denmark's Research Portal Terms of use This work is brought to you by the University of Southern Denmark. Unless otherwise specified it has been shared according to the terms for self-archiving. If no other license is stated, these terms apply: • You may download this work for personal use only. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying this open access version If you believe that this document breaches copyright please contact us providing details and we will investigate your claim. Please direct all enquiries to [email protected] Download date: 07. Oct. 2021 Acta Derm Venereol 2016; 96: 373–376 CLINICAL REPORT Urticaria and Prodromal Symptoms Including Erythema Marginatum in Danish Patients with Hereditary Angioedema Eva Rye RASMUSSEN1,
    [Show full text]
  • Erythema Marginatum
    Figurative Erythemas Michelle Goedken, DO Affiliated Dermatology Scottsdale, AZ Figurative Erythemas • Erythema annulare centrifugum • Erythema marginatum • Erythema migrans • Erythema gyratum repens • Erythema multiforme Erythemas • Erythemas represent a change in the color of the skin that is due to the dilation of blood vessels, especially those in the papillary and reticular dermis • The color is blanchable and most last for days to months • Figurative erythemas have an annular, arciform or polycyclic appearance ERYTHEMA ANNULARE CENTRIFUGUM ERYTHEMA ANNULARE CENTRIFUGUM • Pathogenesis: EAC represents a reaction pattern or hypersensitivity to one of many antigens – IL-2 and TNF-alpha may have a role – Most patients do not have an underlying disease identified ERYTHEMA ANNULARE CENTRIFUGUM • Associated with: – Infection » Dermatophytes and other fungi (Candida and Penicillium in blue cheese) » Viruses: poxvirus, EBV, VZV, HIV » Parasites and ectoparasites – Drugs: diuretics, antimalarials, gold, NSAIDs, finasteride, amitriptyline, etizolam, Ustekinumab (2012) ERYTHEMA ANNULARE CENTRIFUGUM – Foods – Autoimmune endocrinopathies – Neoplasms (lymphomas and leukemias) – Pregnancy – Hypereosinophilic syndrome – Lupus (2014) ERYTHEMA ANNULARE CENTRIFUGUM http://www.dermaamin.com Rongioletti, F., Fausti, V., & Parodi, A ERYTHEMA ANNULARE CENTRIFUGUM • 2 major forms: – Superficial: classic trailing scale, may have associated pruritus – Deep: infiltrated borders, usually no scale, edges are elevated, usually not pruritic ERYTHEMA ANNULARE CENTRIFUGUM
    [Show full text]
  • Pseudomonas Skin Infection Clinical Features, Epidemiology, and Management
    Am J Clin Dermatol 2011; 12 (3): 157-169 THERAPY IN PRACTICE 1175-0561/11/0003-0157/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. Pseudomonas Skin Infection Clinical Features, Epidemiology, and Management Douglas C. Wu,1 Wilson W. Chan,2 Andrei I. Metelitsa,1 Loretta Fiorillo1 and Andrew N. Lin1 1 Division of Dermatology, University of Alberta, Edmonton, Alberta, Canada 2 Department of Laboratory Medicine, Medical Microbiology, University of Alberta, Edmonton, Alberta, Canada Contents Abstract........................................................................................................... 158 1. Introduction . 158 1.1 Microbiology . 158 1.2 Pathogenesis . 158 1.3 Epidemiology: The Rise of Pseudomonas aeruginosa ............................................................. 158 2. Cutaneous Manifestations of P. aeruginosa Infection. 159 2.1 Primary P. aeruginosa Infections of the Skin . 159 2.1.1 Green Nail Syndrome. 159 2.1.2 Interdigital Infections . 159 2.1.3 Folliculitis . 159 2.1.4 Infections of the Ear . 160 2.2 P. aeruginosa Bacteremia . 160 2.2.1 Subcutaneous Nodules as a Sign of P. aeruginosa Bacteremia . 161 2.2.2 Ecthyma Gangrenosum . 161 2.2.3 Severe Skin and Soft Tissue Infection (SSTI): Gangrenous Cellulitis and Necrotizing Fasciitis. 161 2.2.4 Burn Wounds . 162 2.2.5 AIDS................................................................................................. 162 2.3 Other Cutaneous Manifestations . 162 3. Antimicrobial Therapy: General Principles . 163 3.1 The Development of Antibacterial Resistance . 163 3.2 Anti-Pseudomonal Agents . 163 3.3 Monotherapy versus Combination Therapy . 164 4. Antimicrobial Therapy: Specific Syndromes . 164 4.1 Primary P. aeruginosa Infections of the Skin . 164 4.1.1 Green Nail Syndrome. 164 4.1.2 Interdigital Infections . 165 4.1.3 Folliculitis .
    [Show full text]